Browse > Article

Protective Effects of Chalcone Derivatives for Acute Liver Injury in Mice  

Guan Li-Ping (College of Pharmacy, Yan bian University)
Nan Ji-Xing (College of Pharmacy, Yan bian University)
Jin Xue-Jun (College of Pharmacy, Yan bian University)
Jin Qing-Hao (College of Pharmacy, Yan bian University)
Kwak Kyung Chell (Department of Chemistry, Wonkwang University)
Chai Kyu-yun (Department of Chemistry, Wonkwang University)
Quan Zhe-Shan (College of Pharmacy, Yan bian University, Yanji City)
Publication Information
Archives of Pharmacal Research / v.28, no.1, 2005 , pp. 81-86 More about this Journal
Abstract
The hepatoprotective effects of chalcone derivatives were evaluated in D-galactosamine/lipopolysaccharide (D-GaIN/LPS)-induced fulminant hepatic failure in mouse. Thirteen chalcone derivatives were synthesized for study and their hepatoprotective effects were evaluated by assessing aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in serum. Chalcone preparations were injected into mice at 12 hand 1 h before intraperitoneal injection of D-GaIN/LPS. After abdominal administration, changes in AST and ALT between the control and treated groups were observed. Ten of the synthesized chalcone derivatives exhibited inhibitory effects on D-GaIN/LPS-induced levels of AST and ALT in mice. Compounds 2, 3, 8, 9, and 12 markedly reduced serum AST and ALT at 8 h, inhibited hepatocyte necrosis and showed significant hepatoprotective activities. The activity of compound 3 was compared with the bifendate (DDB) through oral administration. Compound 3 showed much higher inhibitory effects than bifendate for decreasing AST and ALT activity. The results indicate that compound 3 has strong hepatoprotective activity through suppression of tumor necrosis factor­alpha (TNF-alpha) preduction, reduction of the histological change in the liver, and attenuated of hepatocyte apoptosis confirmed by DNA fragmentation assay.
Keywords
Chalcone derivatives; Butein; Hepatoprotective activity; Fulminant hepatitis;
Citations & Related Records

Times Cited By Web Of Science : 7  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Kiichiro, K., Seiichi, K., Hirohide, H., Hiroko, M., Hiroyuki, M, and Yoshio, K., Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur. J. Pharmacol., 368, 245-250 (1999)   DOI   ScienceOn
2 Mas, A. and Rodes, J., Fulminant hepatic failure. Lancet, 349, 1081-1085 (1997)   DOI   ScienceOn
3 Morikawa, T., Matsuda, H., Ninomiya, K., and Yoshikawa, M., Medicinal Foodstuffs XXIX. Potent protective effects of sesquiterpenes and curcumin from zedoariae rhizoma on liver injury induced by D-galactosamine/Lipopolysaccharide or tumor necrosis factor-${\alpha}$. Biol. Pharm. Bull., 25, 627-631 (2002)   DOI   ScienceOn
4 Takahashi, K., Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Mu, M. M., Yoshida, T., and Yokochi, T., Flavonoids protect mice from two types of lethal shock induced by endotoxin. FEMS. Immunol. Med. Microbiol., 31, 29-33 (2001)   DOI   ScienceOn
5 Hiseh, H. K., Lee, T. H., Wang, J. P., Wang, J. J., and Lin, C. N., Synthesis and anti-inflammatory effects of chalcones and related compounds. Pharm. Res., 15, 39-46 (1998)   DOI   ScienceOn
6 Kawaguchi, K., Kikuchi, S., Hasegawa, H., Maruyama, H., Morita, H., and Kumazawa, Y., Suppression of lipopolysaccharideinduced tumor necrosis factor-release and liver injury in mice by naringin. Eur. J. Pharmacol., 368, 245-250 (1999)   DOI   ScienceOn
7 Cheng, Z. J., Kuo, S. C., Chan, S. C., Ko, F. N., and Teng, C. M., Antioxidant properties of butein isolated from Dalbergia odorifera. Biochim. Biophys. Acta, 1392, 291-299 (1998)   DOI   ScienceOn
8 Xiong, Q., Hase, K., Tezuka, Y., Namba, T., and Kadota, S., Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury. Life Sci., 65, 421-430 (1999)   DOI   ScienceOn
9 Bekhit, A. A., Habib, N. S., Din, A., and Bekhit, A., Synthesis and antimicrobial evaluation of chalcone and syndrome derivatives of 4(3H)-quinazolinone. Boll. Chim. Farm., 140, 297-301 (2001)
10 Sass, G., Heinlein, S., Agli, A., Bang, R., Schumann, J., and Tiegs, G., Cytokine expression in three mouse models of experimental hepatitis. Cytokine, 19, 115-120 (2002)   DOI   ScienceOn
11 Woo, S. W., Lee, S. H., Kang, H. C., Park, E. J., Zhao, Y. Z., Kim, Y. C., and Sohn, D. H., Butein suppresses myofibroblastic differentiation of rat-hepatic stellate cells in primary culture. J. Pharm. Pharmacol., 55, 347-352 (2003)   DOI   ScienceOn
12 Lopez, S. N., Castelli, M. V., Zacchino, S. A., Dominguez, J. N., Lobo, G., Chrris-Charriss, J., Cortes, J. C., Ribas, J. C., Devia, C., Rodriguez, A. M., and Enrizz, R. D., In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg. Med. Chem., 9, 1999-2013 (2001)   DOI   ScienceOn
13 Arvelo, M. B., Cooper, J. T., Longo, C., Daniel, S., Grey, S. T., Mahiou, J., Czismadia, E., Abu-jawdeh, G., and Ferran, C., A20 protects mice from D-galactosamine/Lipopolysaccharide acute toxic lethal hepatitis. Hepatol., 35, 535-543 (2002)   DOI   ScienceOn
14 Kosai, K. I., Matsumoto, K., Funakoshi, H., and Nakamura, T., Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatol., 30, 151-159 (1999)   DOI   PUBMED
15 Kumar, S. K., Hager, E., Pettit, C., Gurulingppa, H., Davidson, N. E., and Khan, S. R., Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J. Med. Chem., 46, 2813-2815 (2003)   DOI   ScienceOn
16 Wu, J. H., Wang, X. H., Yi, Y. H., and Lee, K. H., Anti-AIDS agents 54, A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg. Med. Chem. Lett., 13, 1813-1815 (2003)   DOI   ScienceOn
17 Liu, M., Wilairat, P., and Go, M. L., Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis. J. Med. Chem., 44, 4443-4452 (2001)   DOI   ScienceOn
18 Murakami, S., Muramatsu, M., Aihara, H., and Otomo, S., Inhibition of gastric $H^+$, $K^+$-ATPase by the antiulcer agent, sofalcone. Biochem. Pharmacol., 42, 1447-1451 (1991)   DOI   PUBMED   ScienceOn
19 Nakama, T., Hirono, S., Moriuchi, A., Hasuike, S., Nagata, K., Hori, T., Ido, A., Hayashi, K., and Tsubouchi, H., Etoposide prevents apoptosis in mouse liver with D-galactosamine/ lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatol., 33, 1441-1450 (2001)   DOI   ScienceOn
20 Galanos, C., Freudenberg, M. A., and Reutter, W., Galactosamine- induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A., 76, 5939-5943 (1979)   DOI   ScienceOn
21 Viana, G. S., Bandeira, M. A., and Matos, F. J., Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva allemao. Phytomedicine, 10, 189- 196 (2003)   DOI   ScienceOn
22 Kim, K., Kim, Y. M., Park, M., Park, K ., Chang, H. K., Park, T. K., Chung, H. H., and Kang, C. Y., A broad spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice. Clin. Immunol., 97, 221-233 (2000)   DOI   ScienceOn
23 Tran, Q. L., Adnyana, I. K., Tezuka, Y., Harimaya, Y., Saiki, I., Kurashige, Y., Tran, Q. K., and Kadota, S., Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng. Planta Med., 68, 402-406 (2002)   DOI   ScienceOn